Literature DB >> 20518547

Synthesis of SL0101 carbasugar analogues: carbasugars via Pd-catalyzed cyclitolization and post-cyclitolization transformations.

Mingde Shan1, George A O'Doherty.   

Abstract

A general approach to the stereoselective synthesis of 5a-carbasugars has been developed. The route mimics our palladium-catalyzed glycosylation/postglycosylation approach to carbohydrates in that it also utilizes a highly regio- and stereospecific palladium-catalyzed allylation and postglycosylation reaction sequence for the installation of either D- or L-cyclitols. This cyclitolization/postcyclitolization sequence was used for the enantioselective synthesis of a cyclitol analogue of SL0101, its D-sugar enantiomer, as well as several acetylation pattern analogues.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518547      PMCID: PMC2892554          DOI: 10.1021/ol101009q

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  14 in total

1.  Synthesis of a potent and selective inhibitor of p90 Rsk.

Authors:  David J Maloney; Sidney M Hecht
Journal:  Org Lett       Date:  2005-03-17       Impact factor: 6.005

2.  Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation.

Authors:  Jeffrey A Smith; Celeste E Poteet-Smith; Yaming Xu; Timothy M Errington; Sidney M Hecht; Deborah A Lannigan
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

3.  Influence of rhamnose substituents on the potency of SL0101, an inhibitor of the Ser/Thr kinase, RSK.

Authors:  Jeffrey A Smith; David J Maloney; David E Clark; Yaming Xu; Sidney M Hecht; Deborah A Lannigan
Journal:  Bioorg Med Chem       Date:  2006-05-24       Impact factor: 3.641

4.  gem-Difluoro-carbasugars, the cases of mannopyranose and galactopyranose.

Authors:  João Sardinha; Samuel Guieu; Aurélie Deleuze; M Carmen Fernández-Alonso; Amelia Pilar Rauter; Pierre Sinaÿ; Jérôme Marrot; Jesús Jiménez-Barbero; Matthieu Sollogoub
Journal:  Carbohydr Res       Date:  2007-05-23       Impact factor: 2.104

5.  De novo asymmetric syntheses of SL0101 and its analogues via a palladium-catalyzed glycosylation.

Authors:  Mingde Shan; George A O'Doherty
Journal:  Org Lett       Date:  2006-10-26       Impact factor: 6.005

Review 6.  Targeting RSK: an overview of small molecule inhibitors.

Authors:  Tam Luong Nguyen
Journal:  Anticancer Agents Med Chem       Date:  2008-10       Impact factor: 2.505

7.  Synthesis of carbasugar C-1 phosphates via Pd-catalyzed cyclopropanol ring opening.

Authors:  Mingde Shan; George A O'Doherty
Journal:  Org Lett       Date:  2008-07-18       Impact factor: 6.005

8.  Structural basis for the activity of the RSK-specific inhibitor, SL0101.

Authors:  Jeffrey A Smith; David J Maloney; Sidney M Hecht; Deborah A Lannigan
Journal:  Bioorg Med Chem       Date:  2007-04-02       Impact factor: 3.641

9.  A palladium-catalyzed glycosylation reaction: the de novo synthesis of natural and unnatural glycosides.

Authors:  Ravula Satheesh Babu; George A O'Doherty
Journal:  J Am Chem Soc       Date:  2003-10-15       Impact factor: 15.419

10.  De novo synthesis of oligosaccharides using a palladium-catalyzed glycosylation reaction.

Authors:  Ravula Satheesh Babu; Maoquan Zhou; George A O'Doherty
Journal:  J Am Chem Soc       Date:  2004-03-24       Impact factor: 15.419

View more
  13 in total

1.  De novo asymmetric synthesis of the mezzettiaside family of natural products via the iterative use of a dual B-/Pd-catalyzed glycosylation.

Authors:  Sumit O Bajaj; Ehesan U Sharif; Novruz G Akhmedov; George A O'Doherty
Journal:  Chem Sci       Date:  2014-06       Impact factor: 9.825

2.  Synthesis of several cleistrioside and cleistetroside natural products via a divergent de novo asymmetric approach.

Authors:  Bulan Wu; Miaosheng Li; George A O'Doherty
Journal:  Org Lett       Date:  2010-11-01       Impact factor: 6.005

3.  Recent Advances in Transition Metal-Catalyzed Glycosylation.

Authors:  Matthew J McKay; Hien M Nguyen
Journal:  ACS Catal       Date:  2012-06-14       Impact factor: 13.084

4.  Synthesis and Structure-Activity Relationship Study of 5a-Carbasugar Analogues of SL0101.

Authors:  Mingzong Li; Yu Li; Roman M Mrozowski; Zachary M Sandusky; Mingde Shan; Xiwen Song; Bulan Wu; Qi Zhang; Deborah A Lannigan; George A O'Doherty
Journal:  ACS Med Chem Lett       Date:  2014-11-26       Impact factor: 4.345

5.  Regioselective Synthesis of a C-4'' Carbamate,C-6'' n-Pr Substituted Cyclitol Analogue of SL0101.

Authors:  Yu Li; Zachary M Sandusky; Rajender Vemula; Qi Zhang; Bulan Wu; Shinji Fukuda; Mingzong Li; Deborah A Lannigan; George A O'Doherty
Journal:  Org Lett       Date:  2020-02-03       Impact factor: 6.005

6.  Synthesis and Biological Evaluation of 4'-Substituted Kaempfer-3-ols.

Authors:  Sugyeom Kim; Yu Li; Lin Lin; Peyton R Sayasith; Ariel T Tarr; Eric B Wright; Sharia Yasmin; Deborah A Lannigan; George A O'Doherty
Journal:  J Org Chem       Date:  2020-02-27       Impact factor: 4.354

7.  Structure Activity Relationship Study of the Cleistriosides and Cleistetrosides for Antibacterial/Anticancer Activity.

Authors:  Pei Shi; Michelle C Silva; Hua-Yu Leo Wang; Bulan Wu; Novruz G Akhmedov; Miaosheng Li; Penny J Beuning; George A O'Doherty
Journal:  ACS Med Chem Lett       Date:  2012-10-30       Impact factor: 4.345

8.  Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability.

Authors:  Michael K Hilinski; Roman M Mrozowski; David E Clark; Deborah A Lannigan
Journal:  Bioorg Med Chem Lett       Date:  2012-03-13       Impact factor: 2.823

9.  The affinity of RSK for cylitol analogues of SL0101 is critically dependent on the B-ring C-4'-hydroxy.

Authors:  Yu Li; Pedro Seber; Eric B Wright; Sharia Yasmin; Deborah A Lannigan; George A O'Doherty
Journal:  Chem Commun (Camb)       Date:  2020-03-10       Impact factor: 6.222

10.  Improving the affinity of SL0101 for RSK using structure-based design.

Authors:  Roman M Mrozowski; Rajender Vemula; Bulan Wu; Qi Zhang; Benjamin R Schroeder; Michael K Hilinski; David E Clark; Sidney M Hecht; George A O'Doherty; Deborah A Lannigan
Journal:  ACS Med Chem Lett       Date:  2012-12-26       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.